Carl read the papersWhat it actually is
This is a guide, not a single peptide: which peptides women on r/PeptidesForWomen run, and how dosing and safety differ.
The core rule is start low and titrate, favour zero-androgenic compounds (no virilization), and treat the tirzepatide × oral birth-control interaction as the real safety lever.
How it’s thought to work
- Lower body mass — women often need lower absolute doses than male-forum defaults.
- Zero-androgenic preference — BPC-157, GHK-Cu, TB-500, GLP-1s — no virilization risk.
- Cycle-phase sensitivity — GLP-1 nausea reported worse in the luteal phase.
- The real interaction — tirzepatide can reduce oral birth-control absorption (semaglutide's label shows no meaningful drop) — the key safety point.
What the research says
Female-specific peptide data is very thin; there is no clinical data on efficacy by cycle phase. Cycle-timing advice is community/practitioner lore, not proven.
- Start-low-titrate rule for every compound.
- Most-used tier: BPC-157, GHK-Cu, TB-500, GLP-1s. Only the GLP-1s have big human trials (GHK-Cu has small topical skin studies); the FDA flags BPC-157, TB-500 and injectable GHK-Cu as possible safety risks in compounding.
- Avoid Melanotan II; COA everything.
Reported protocols
These are the doses the peptide community actually reports running (Reddit & forums), alongside published research — logged for education, not as a recommendation to use.
| Parameter | Commonly reported range |
|---|---|
| BPC-157 | ~250 mcg (up to ~350) 1–2×/day, weight-scaled — gut/joint healing |
| GHK-Cu | 1000–2000 mcg/day subQ 5 days/wk (± 1–3% topical) — skin/hair/glow |
| PT-141 | 0.5 mg start (max ~2 mg) — libido (~40% nausea) |
| GLP-1s | Semaglutide 0.25→2.4 mg/wk; Tirzepatide 2.5→15 mg/wk (many microdose) |
| Community tip | Halve the male ‘bro-dose’ and see how you feel first |
Common use cases
| Goal | Community protocol notes |
|---|---|
| Skin / hair / glow | GHK-Cu 1–2 mg/day 5×/wk ± topical |
| Healing | BPC-157 ~250 mcg 1–2×/day, ± TB-500 |
| Weight loss | a microdosed, slowly-titrated GLP-1 — mind the BC interaction |
Mixing it (reconstitution)
Freeze-dried peptides must be reconstituted with bacteriostatic water before they can be measured. Carl’s calculator turns “mg in the vial + ml of water + target dose” into “units on the syringe” — and tells you how long the vial lasts.
→ Open the Reconstitution Calculator
Injection & handling
Varies by compound (most subQ; GHK-Cu also topical; PT-141 subQ/nasal). The through-line: start at the low end, titrate slowly, rotate sites, and COA everything. Stop all peptides before conception and during pregnancy/breastfeeding.
Stacks it appears in
- The Glow — GHK-Cu + BPC-157 / TB-500 — the popular zero-androgenic skin + healing combo.
- Fat loss — a GLP-1, microdosed and titrated slowly.
Sources
- Mounjaro (tirzepatide) US label, DailyMed
- Zepbound (tirzepatide) US label, DailyMed
- Wegovy (semaglutide) US label, DailyMed
- Semaglutide does not reduce oral contraceptive bioavailability, J Clin Pharmacol 2015 (PMID 25475122)
- FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
- Vyleesi (bremelanotide) US label, DailyMed
- Risks of unregulated melanotan use review, Int J Dermatol 2017 (PMID 28266027)
